Singapore Institute of Advanced Medicine (SGX:9G2) allotted and issued 3,921,568 new shares at SG$0.051 per share under the vesting of awards to eligible participants as part of its performance incentive.
The new shares are expected to be listed and quoted on the Catalist board on or around Feb. 13, according to a filing with the Singapore Exchange on Tuesday.
Following the allotment of the new shares, the total number of issued and paid-up shares has increased to 1.05 billion.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。